|
1
|
Barde YA: Trophic factors and neuronal
survival. Neuron. 2:1525–1534. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bartkowska K, Turlejski K and Djavadian
RL: Neurotrophins and their receptors in early development of the
mammalian nervous system. Acta Neurobiol Exp. 70:454–467.
2010.PubMed/NCBI
|
|
3
|
Zhou XF, Song XY, Zhong JH, Barati S, Zhou
FH and Johnson SM: Distribution and localization of
pro-brain-derived neurotrophic factor-like immunoreactivity in the
peripheral and central nervous system of the adult rat. J
Neurochem. 91:704–715. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Seidah NG and Chretien M: Proprotein and
prohormone convertases: a family of subtilases generating diverse
bioactive polypeptides. Brain Res. 848:45–62. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Barker PA: Whither proBDNF? Nat Neurosci.
12:105–106. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Teng HK, Teng KK, Lee R, Wright S, Tevar
S, Almeida RD, Kermani P, Torkin R, Chen ZY, Lee FS, Kraemer RT,
Nykjaer A and Hempstead BL: ProBDNF induces neuronal apoptosis via
activation of a receptor complex of p75NTR and sortilin. J
Neurosci. 25:5455–5463. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kenchappa RS, Zampieri N, Chao MV, Barker
PA, Teng HK, Hempstead BL and Carter BD: Ligand-dependent cleavage
of the P75 neurotrophin receptor is necessary for NRIF nuclear
translocation and apoptosis in sympathetic neurons. Neuron.
50:219–232. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fan YJ, Wu LL, Li HY, Wang YJ and Zhou XF:
Differential effects of pro-BDNF on sensory neurons after sciatic
nerve transection in neonatal rats. Eur J Neurosci. 27:2380–2390.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Desmet CJ and Peeper DS: The neurotrophic
receptor TrkB: a drug target in anti-cancer therapy? Cell Mol Life
Sci. 63:755–759. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hamel W, Westphal M, Szonyi E, Escandon E
and Nikolics K: Neurotrophin gene expression by cell lines derived
from human gliomas. J Neurosci Res. 34:147–157. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Assimakopoulou M, Kondyli M, Gatzounis G,
Maraziotis T and Varakis J: Neurotrophin receptors expression and
JNK pathway activation in human astrocytomas. BMC Cancer.
7:2022007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Aronica E, Leenstra S, Jansen GH, van
Veelen CW, Yankaya B and Troost D: Expression of brain-derived
neurotrophic factor and tyrosine kinase B receptor proteins in
glioneuronal tumors from patients with intractable epilepsy:
colocalization with N-methyl-D-aspartic acid receptor. Acta
Neuropathol. 101:383–392. 2001.
|
|
13
|
Xiong J, Zhou L, Yang M, Lim Y, Zhu YH, Fu
DL, Li ZW, Zhong JH, Xiao ZC and Zhou XF: ProBDNF and its receptors
are upregulated in glioma and inhibit the growth of glioma cells in
vitro. Neuro Oncol. 15:990–1007. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Akil H, Perraud A, Melin C, Jauberteau MO
and Mathonnet M: Fine-tuning roles of endogenous brain-derived
neurotrophic factor, TrkB and sortilin in colorectal cancer cell
survival. PloS One. 6:e250972011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kelly KJ, Sandoval RM, Dunn KW, Molitoris
BA and Dagher PC: A novel method to determine specificity and
sensitivity of the TUNEL reaction in the quantitation of apoptosis.
Am J Physiol Cell Physiol. 284:C1309–C1318. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu ZQ, Sun Y, Li HY, Lim Y, Zhong JH and
Zhou XF: Endogenous proBDNF is a negative regulator of migration of
cerebellar granule cells in neonatal mice. Eur J Neurosci.
33:1376–1384. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Woo NH, Teng HK, Siao CJ, Chiaruttini C,
Pang PT, Milner TA, Hempstead BL and Lu B: Activation of p75NTR by
proBDNF facilitates hippocampal long-term depression. Nat Neurosci.
8:1069–1077. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lu B: Pro-region of neurotrophins: role in
synaptic modulation. Neuron. 39:735–738. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lu B, Pang PT and Woo NH: The yin and yang
of neurotrophin action. Nat Rev Neurosci. 6:603–614. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Koshimizu H, Hazama S, Hara T, Ogura A and
Kojima M: Distinct signaling pathways of precursor BDNF and mature
BDNF in cultured cerebellar granule neurons. Neurosci Lett.
473:229–232. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun Y, Lim Y, Li F, Liu S, Lu JJ,
Haberberger R, Zhong JH and Zhou XF: ProBDNF collapses neurite
outgrowth of primary neurons by activating RhoA. PLoS One.
7:e358832012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang YT, Lai PC, Wu CC, Hsu SH, Cheng CC,
Lan YF and Chiu TH: BDNF mediated TrkB activation is a survival
signal for transitional cell carcinoma cells. Int J Oncol.
36:1469–1476. 2010.PubMed/NCBI
|
|
23
|
Lam CT, Yang ZF, Lau CK, Tam KH, Fan ST
and Poon RT: Brain-derived neurotrophic factor promotes
tumorigenesis via induction of neovascularization: implication in
hepatocellular carcinoma. Clin Cancer Res. 17:3123–3133. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pearse RN, Swendeman SL, Li Y, Rafii D and
Hempstead BL: A neurotrophin axis in myeloma: TrkB and BDNF promote
tumor-cell survival. Blood. 105:4429–4436. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Thiele CJ, Li Z and McKee AE: On Trk - the
TrkB signal transduction pathway is an increasingly important
target in cancer biology. Clin Cancer Res. 15:5962–5967. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Haapasalo A, Sipola I, Larsson K, Akerman
KE, Stoilov P, Stamm S, Wong G and Castren E: Regulation of TRKB
surface expression by brain-derived neurotrophic factor and
truncated TRKB isoforms. J Biol Chem. 277:43160–43167. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Haapasalo A, Saarelainen T, Moshnyakov M,
Arumae U, Kiema TR, Saarma M, Wong G and Castren E: Expression of
the naturally occurring truncated trkB neurotrophin receptor
induces outgrowth of filopodia and processes in neuroblastoma
cells. Oncogene. 18:1285–1296. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Edsjo A, Lavenius E, Nilsson H, Hoehner
JC, Simonsson P, Culp LA, Martinsson T, Larsson C and Pahlman S:
Expression of trkB in human neuroblastoma in relation to MYCN
expression and retinoic acid treatment. Lab Invest. 83:813–823.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ho R, Eggert A, Hishiki T, Minturn JE,
Ikegaki N, Foster P, Camoratto AM, Evans AE and Brodeur GM:
Resistance to chemotherapy mediated by TrkB in neuroblastomas.
Cancer Res. 62:6462–6466. 2002.PubMed/NCBI
|
|
30
|
Han L, Zhang Z, Qin W and Sun W:
Neurotrophic receptor TrkB: is it a predictor of poor prognosis for
carcinoma patients? Med Hypotheses. 68:407–409. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Goebell E, Paustenbach S, Vaeterlein O,
Ding XQ, Heese O, Fiehler J, Kucinski T, Hagel C, Westphal M and
Zeumer H: Low-grade and anaplastic gliomas: differences in
architecture evaluated with diffusion-tensor MR imaging. Radiology.
239:217–222. 2006. View Article : Google Scholar : PubMed/NCBI
|
